HNGE — Hinge Health Cashflow Statement
0.000.00%
Last trade - 00:00- $4.02bn
- $3.61bn
- $390.40m
Annual cashflow statement for Hinge Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Net Income/Starting Line | -108 | -11.9 |
| Depreciation | ||
| Deferred Taxes | ||
| Non-Cash Items | 29.7 | 42.1 |
| Other Non-Cash Items | ||
| Changes in Working Capital | -26.6 | -63.7 |
| Change in Accounts Receivable | ||
| Change in Inventories | ||
| Change in Prepaid Expenses | ||
| Change in Other Assets | ||
| Change in Accrued Expenses | ||
| Change in Payable / Accrued Expenses | ||
| Cash from Operating Activities | -63.9 | 49 |
| Capital Expenditures | -4.62 | -3.77 |
| Purchase of Fixed Assets | ||
| Other Investing Cash Flow Items | 6.12 | 22.1 |
| Sale/Maturity of Investment | ||
| Purchase of Investments | ||
| Cash from Investing Activities | 1.5 | 18.3 |
| Financing Cash Flow Items | -3.49 | -2.81 |
| Other Financing Cash Flow | ||
| Net Issuance / Retirement of Stock | ||
| Cash from Financing Activities | -3 | -2.2 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | -65.4 | 65.1 |